Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy.
doi.org/10.1093/abt/...
#bispecificantibodies #bsab #bsabs #atopicdermatitis #th2cytokines #il4rα #il31rα
@antibodytx.bsky.social